Chemotherapeutic approaches to trematodes (except schistosomes) and cestodes: current level of knowledge and outlook.
Harder
A
A
Biological Chemical Evaluation, Animal Health Business Group, Bayer AG Monheim, 51368 Leverkusen, Germany. achim.harder.ah@bayer-ag.de
D000818:Animals; D000923:Anticestodal Agents / Q000145:classification / Q000494:pharmacology / Q000627:therapeutic use*; D000980:Antiplatyhelmintic Agents / Q000145:classification / Q000494:pharmacology / Q000627:therapeutic use*; D002589:Cestoda / Q000187:drug effects; D002590:Cestode Infections / Q000188:drug therapy* / Q000453:epidemiology / Q000378:metabolism; D005544:Forecasting; D010085:Oxidative Phosphorylation; D012547:Schistosoma / Q000187:drug effects; D014200:Trematoda / Q000187:drug effects; D014201:Trematode Infections / Q000188:drug therapy* / Q000453:epidemiology / Q000378:metabolism
D000923:Anticestodal Agents; D000980:Antiplatyhelmintic Agents